· 03/10/2018
Clinical Trial KESTREL: Efficacy and safety of brolucizumab in comparison with aflibercept in diabetic macular edema
· 03/10/2018
Clinical trial THR-317-002: Efficacy and safety of THR-317 with ranibizumab in the treatment of diabetic macular oedema
· 01/10/2018
Clinical Trial OAKS and DERBY: Efficacy and safety of APL-2 in the treatment of geographic atrophy secondary to AMD
· 10/05/2018
Clinical trial OPH2005: Efficacy and safety of Zimura in the treatment of Stargardt’s disease
· 31/03/2016
Proxima A: Epidemiological study of the progression of Geographic Atrophy secondary to Age-Related Macular Degeneration (GX29633)
· 31/03/2016
Proxima B: Epidemiological study of the progression of Geographic Atrophy secondary to Age-Related Macular Degeneration (GX29639)
· 21/09/2015
HARRIER: Clinical trial on patients with choroidal neovascularisation secondary to AMD
· 29/01/2015
CHROMA: Clinical Trial of Lampalizumab for Geographic Atrophy Secondary to Age-Related Macular Degeneration
· 19/12/2014
FOVISTA NR: Clinical Trial for neovascular age-related macular degeneration
· 21/12/2014
LITE: Development of Advanced Laser Imaging Techniques for the anterior and posterior Eye
· 01/01/2015
FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration
· 19/03/2014Recruiting
Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD
· 31/03/2014
Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD
· 20/12/2014
MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration
· 20/12/2014
Oral Omega 3 GA. A phase II in subjects with geographic atrophy secondary to AMD